产品展厅
|

| 用途 | - |
| 型号 | - |
| 包装规格 | - |
| 外观 | - |
| CAS编号 | 923978-27-2 |
| 别名 | Elafibranor (GFT505) |
| 纯度 | 99% |
| 重金属 | 10ppm |
Elafibranor (GFT505)
别名】 GFT505
【CAS号】 923978-27-2
【纯度】 98%
【分子式】 C22H24O4S
【分子量】 384.49
【简介】 Elafibranor (GFT505) is Genfit’s lead pipeline product. It’s an oral once-daily treatment, positioned as a first-in-class drug to treat nonalcoholic steatohepatitis (NASH).
Elafibranor (GFT505) is Genfit’s lead pipeline product. It’s an oral once-daily treatment, positioned as a first-in-class drug to treat nonalcoholic steatohepatitis (NASH). Based on the beneficial activities that it demonstrates on the different features of the pathology, Elafibranor represents the ideal drug for NASH patients, including those suffering from the most severe forms of the disease.
The new non-proprietary name, Elafibranor, reflects the first-in-class nature of the drug candidate, since it does not contain a pre-existing INN stem. The novel pre-stem “-fibranor” may thus become an established stem over time, as other later developed drugs are recognized to be related in structure or activity.
生产厂家 价格 供应商